APA (7th ed.) Citation

Guo, H., Shen, H., Wang, L., Luo, Z., Zhang, J., Zhang, H., . . . Jiang, J. (2023). Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases. Biomedicine & pharmacotherapy, 163, 114754. https://doi.org/10.1016/j.biopha.2023.114754

Chicago Style (17th ed.) Citation

Guo, Hui-Hui, Hao-Ran Shen, Lu-Lu Wang, Zhi-Gang Luo, Jin-Lan Zhang, Hong-Juan Zhang, Tian-Le Gao, Yan-Xing Han, and Jian-Dong Jiang. "Berberine Is a Potential Alternative for Metformin with Good Regulatory Effect on Lipids in Treating Metabolic Diseases." Biomedicine & Pharmacotherapy 163 (2023): 114754. https://doi.org/10.1016/j.biopha.2023.114754.

MLA (9th ed.) Citation

Guo, Hui-Hui, et al. "Berberine Is a Potential Alternative for Metformin with Good Regulatory Effect on Lipids in Treating Metabolic Diseases." Biomedicine & Pharmacotherapy, vol. 163, 2023, p. 114754, https://doi.org/10.1016/j.biopha.2023.114754.